Dexlansoprazole

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 23 USDMF, 11 EU WC, 8 KDMF, 18 NDC API, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

47 FDF Dossiers, 9 FDA Orange Book, 8 Europe, 6 Canada, 24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - 30MG, CAPSULE, DELAYED RELEASE;ORAL - 60MG

RELATED EXCIPIENT COMPANIES

6 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 6 DKSH, 2 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 14 Corel Pharma Chem, 1 Finar, 8 Gangwal Chemicals, 12 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 12 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 13 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

63 Coating Systems & Additives, 31 Controlled & Modified Release, 19 Fillers, Diluents & Binders, 17 Solubilizers, 12 Film Formers & Plasticizers, 11 Thickeners and Stabilizers, 9 Taste Masking, 8 Parenteral, 7 Direct Compression, 7 Emulsifying Agents, 6 Co-Processed Excipients, 5 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 5 Disintegrants & Superdisintegrants, 4 Coloring Agents, 4 Chewable & Orodispersible Aids, 4 Lubricants & Glidants, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 3 Granulation, 3 Topical, 1 Soft Gelatin